In part 1 of the presentation, Richard E. Goldstein, DVM, DACVIM (SAIM), DECVIM-CA, discusses prevention of tick borne disease, including tick removal, tick control and vaccination. The question of why vaccinate and who to vaccinate in Lyme endemic areas and emerging area will be discussed and then different types of available vaccines.
In part 2 of the discussion, Richard Marconi, PhD will discuss the development and design of a new and novel experimental Lyme disease vaccine. The concept of a chimeritope vaccine will be detailed. The potential advantages of chimeritope vaccines over bacterins or traditional subunit vaccines will be emphasized. Data will be presented that demonstrates the protective efficacy of a prototype chimeritope that is comprised of a series of diverse linear epitopes derived from the OspC protein of the Lyme disease spirochetes.Please note: If you were an attendee at this NAVC Conference and received a general CE certificate, please be sure to check with your state licensing bureau regarding your eligibility to receive online credit for an individual session.
Supported and produced by educational grants from Zoetis in conjunction with NAVC 2016 as part of the Zoetis Infectious Disease Symposium.